CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 6, December

Editorial [Hot topic: Endocannabinoid Receptor System (Guest Editor: Robyn A. Puffenbarger)]

Volume:8   Issue: 6
Pp: 402-402
Robyn A. Puffenbarger
DOI: 10.2174/187152709789824570
Published on: 01 March, 2012

The Endocannabinoid System and Pain

Volume:8   Issue: 6
Pp: 403-421
Josee Guindon and Andrea G. Hohmann
DOI: 10.2174/187152709789824660
Published on: 01 March, 2012

Signal Transduction via Cannabinoid Receptors

Volume:8   Issue: 6
Pp: 422-431
George D. Dalton, Caroline E. Bass, Cynthia G. Van Horn and Allyn C. Howlett
DOI: 10.2174/187152709789824615
Published on: 01 March, 2012

Cannabinoids and Parkinsons Disease

Volume:8   Issue: 6
Pp: 432-439
Moises Garcia-Arencibia, Concepcion Garcia and Javier Fernandez-Ruiz
DOI: 10.2174/187152709789824642
Published on: 01 March, 2012

Cannabinoids and Neurodegenerative Diseases

Volume:8   Issue: 6
Pp: 440-450
Julian Romero and Jose Martinez-Orgado
DOI: 10.2174/187152709789824589
Published on: 01 March, 2012

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

Volume:8   Issue: 6
Pp: 451-458
Matthew N. Hill and Boris B. Gorzalka
DOI: 10.2174/187152709789824624
Published on: 01 March, 2012

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Volume:8   Issue: 6
Pp: 470-474
Kenji Hashimoto
DOI: 10.2174/187152709789824633
Published on: 01 March, 2012

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease

Volume:8   Issue: 6
Pp: 475-491
Kari A. Johnson, P. Jeffrey Conn and Colleen M. Niswender
DOI: 10.2174/187152709789824606
Published on: 01 March, 2012

Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes

Volume:8   Issue: 6
Pp: 492-511
Paula I. Moreira, Sandra M. Cardoso, Claudia M. Pereira, Maria S. Santos and Catarina R. Oliveira
DOI: 10.2174/187152709789824651
Published on: 01 March, 2012

Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes

Volume:8   Issue: 6
Pp: 512-519
Oleksandra Katrych, Tessa M. Simone, Shara Azad and Shaker A. Mousa
DOI: 10.2174/187152709789824598
Published on: 01 March, 2012